Has the time come for these stocks?

► If you enjoyed the episode, please leave us a good review!

► More from PIF: https://linktr.ee/practicalislamicfinance

Has the time come for these stocks?

In this episode, we will cover:

• Introduction and revisiting a past investing idea.
•  Identifying out-of-favor opportunities with potential. 
• Gene editing technology and its investment prospects. 
• Evolution of therapeutic strategies and benefits of CRISPR. 
• Potential cures and advantages of gene editing. 
• FDA-approved CRISPR therapy for sickle cell disease and beta-thalassemia.
• Major players: CRISPR Therapeutics, Intellia, and Beam. 
• Comparing the financial health and pipelines of these companies. 
• Analyst price targets and investment opportunities. 
• Audience Q&A on biotech investing and real estate.

CONTACT US

[email protected]

ABOUT OUR PODCAST

Our podcast is about helping people ethically build wealth. We cover a broad range of topics including stock and crypto investing, product reviews, and general financial well-being.

DISCLAIMER

Anything you hear in this video is an opinion. It is not personalized financial advice. Make sure you do your due diligence before making any investment decisions.